Events Partner Content STING & TLR Targeting Therapies Summit Investigating the cGAS-STING and TLR pathways
Events Partner Content TIGIT Therapies Digital Summit Harnessing TIGIT Checkpoint Inhibitor Therapies
Partner Content Partner Content Updates on Keytruda and future potential therapies advanceme... SMi Group reports on preparations for SMi's inaugural Immuno-Oncology Conference, which is scheduled to take place 26 - 27 September in London.
News Senju launches first-in-class dry eye disease drug in Japan Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
